HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Cosmetics Sector Needs Positive, Not Punitive, 21st Century Regulation – IBA

Executive Summary

Independent Beauty Association president Ken Marenus discusses the trade group’s vision for modern, proportionate cosmetics regulation and forces at work that could undermine progress and endanger small businesses.

You may also be interested in...



Four Federal Cosmetics Bills On Cusp Of Introduction

Ostensibly taking cues from California and lessons from previous congressional sessions, US lawmakers, NGOs and “forward-thinking cosmetics companies” seek piecemeal cosmetics reform via four federal bills slated for introduction in the coming week.

US Cosmetics Reform Bill Would Require FDA Regulation Of ‘Natural’ Labeling

Beautycounter and Burt’s Bees are among the most vocal companies pushing for modernization of US cosmetics regulations via the proposed Personal Care Products Safety Act, which would require the FDA to establish a “natural” definition for use in product labeling.

US FDA Highlights Work To Advance Predictive Toxicology, Non-Animal Testing For Cosmetics

The FDA’s cosmetics office is exploring integrated testing strategies to identify potential skin sensitizers without use of animals, as well as use of in vitro assays to evaluate cosmetic ingredients’ dermal penetration potential. Meanwhile, CFSAN is testing the effects of substances on gene expression in collaboration with other federal agencies as part of Tox21-Phase III.

Related Content

Topics

UsernamePublicRestriction

Register

RS151017

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel